0001209191-19-005421.txt : 20190125 0001209191-19-005421.hdr.sgml : 20190125 20190125181524 ACCESSION NUMBER: 0001209191-19-005421 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190123 FILED AS OF DATE: 20190125 DATE AS OF CHANGE: 20190125 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TANG KEVIN C CENTRAL INDEX KEY: 0001178579 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36282 FILM NUMBER: 19543511 MAIL ADDRESS: STREET 1: 4747 EXECUTIVE DRIVE STREET 2: SUITE 510 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4550 TOWNE CENTRE COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-207-4264 MAIL ADDRESS: STREET 1: 4550 TOWNE CENTRE COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-01-23 0 0000920465 LA JOLLA PHARMACEUTICAL CO LJPC 0001178579 TANG KEVIN C 4747 EXECUTIVE DRIVE, SUITE 510 SAN DIEGO CA 92121 1 0 1 0 Stock Option (Right to Buy) 5.99 2019-01-23 4 A 0 12000 0.00 A 2029-01-23 Common Stock 12000 12000 D The stock options vest and become exercisable on January 23, 2020, subject to the Reporting Person's continued service to the Issuer through such date. /s/ Kevin Tang 2019-01-25